These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16865255)

  • 1. The morphology of perinecrotic tumor cell nuclei in glioblastomas shows a significant relationship with survival time.
    Nafe R; Franz K; Schlote W; Schneider B
    Oncol Rep; 2006 Sep; 16(3):555-62. PubMed ID: 16865255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphology of tumor cell nuclei is significantly related with survival time of patients with glioblastomas.
    Nafe R; Franz K; Schlote W; Schneider B
    Clin Cancer Res; 2005 Mar; 11(6):2141-8. PubMed ID: 15788659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative investigation of nuclear morphology in glioblastomas and its relation to survival time.
    Nafe R; Franz K; Schlote W; Schneider B
    Clin Neuropathol; 2003; 22(3):129-36. PubMed ID: 12809355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glioblastomas: clinical study and search for prognostic factors].
    Mineo JF; Quintin-Roue I; Lucas B; Buburusan V; Besson G
    Neurochirurgie; 2002 Dec; 48(6):500-9. PubMed ID: 12595806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR gene amplification in glioblastomas. Is there a relationship with morphology of tumor cell nuclei and proliferative activity?
    Nafe R; Glienke W; Schlote W; Schneider B
    Anal Quant Cytol Histol; 2001 Apr; 23(2):135-43. PubMed ID: 11332080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome.
    Preusser M; Wolfsberger S; Czech T; Slavc I; Budka H; Hainfellner JA
    Am J Clin Pathol; 2005 Oct; 124(4):543-9. PubMed ID: 16146813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of nuclear size and internuclear distance are important criteria for grading astrocytomas.
    Nafe R; Van de Nes J; Yan B; Schlote W
    Clin Neuropathol; 2006; 25(1):48-56. PubMed ID: 16465775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between preoperative magnetic resonance spectroscopic data on high grade gliomas and morphology of Ki-67-positive tumor cell nuclei.
    Nafe R; Herminghaus S; Raab P; Wagner S; Pilatus U; Schlote W; Zanella F; Lanfermann H
    Anal Quant Cytol Histol; 2003 Jun; 25(3):131-8. PubMed ID: 12882084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histomorphometry of tumour cell nuclei in astrocytomas using shape analysis, densitometry and topometric analysis.
    Nafe R; Schlote W; Schneider B
    Neuropathol Appl Neurobiol; 2005 Feb; 31(1):34-44. PubMed ID: 15634229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of nuclear morphometry of breast cancer in histological sections with clinicopathological features and prognosis.
    Abdalla F; Boder J; Markus R; Hashmi H; Buhmeida A; Collan Y
    Anticancer Res; 2009 May; 29(5):1771-6. PubMed ID: 19443402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of proliferating cell nuclear antigen assessment, histologic parameters and age with survival in patients with glioblastoma multiforme.
    Karkavelas G; Mavropoulou S; Fountzilas G; Christoforidou V; Karavelis A; Foroglou G; Papadimitriou C
    Anticancer Res; 1995; 15(2):531-6. PubMed ID: 7763035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible cyclooxygenase (COX-2) in glioblastoma--clinical and immunohistochemical (COX-2-VEGF) correlations.
    Buccoliero AM; Caldarella A; Gheri CF; Taddei A; Paglierani M; Pepi M; Mennonna P; Taddei GL
    Clin Neuropathol; 2006; 25(2):59-66. PubMed ID: 16550738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
    Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
    Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
    Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
    J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
    Abadie JJ; Amardeilh MA; Delverdier ME
    J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative immunohistochemical analysis of aurora-A and aurora-B expression in human glioblastomas. Associations with proliferative activity and clinicopathological features.
    Samaras V; Stamatelli A; Samaras E; Arnaoutoglou C; Arnaoutoglou M; Stergiou I; Konstantopoulou P; Varsos V; Karameris A; Barbatis C
    Pathol Res Pract; 2009; 205(11):765-73. PubMed ID: 19616898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas.
    Cassoni P; Senetta R; Castellano I; Ortolan E; Bosco M; Magnani I; Ducati A
    Am J Surg Pathol; 2007 May; 31(5):760-9. PubMed ID: 17460461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylated Pak1 level in the cytoplasm correlates with shorter survival time in patients with glioblastoma.
    Aoki H; Yokoyama T; Fujiwara K; Tari AM; Sawaya R; Suki D; Hess KR; Aldape KD; Kondo S; Kumar R; Kondo Y
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6603-9. PubMed ID: 18006760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
    Saeger W; Lüdecke B; Lüdecke DK
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor size and karyometric variables in brain astrocytoma.
    Kostic A; Mihailovic D; Veselinovic S; Tasic D; Stefanovic I; Novak V; Stojanovic N; Veselinovic D; Pavlovic S
    J BUON; 2009; 14(3):473-7. PubMed ID: 19810141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.